Agenda added below!
Virtual Annual IGG Meeting 2020
New ways with old data
We have four very respected scientists covering our two themes of use of adverse outcome pathways for genotoxicity assessment, and the utility of duplex sequencing technology. More details on the agenda coming soon!
We look forward to welcoming you to our virtual meeting and thank UKEMS for supporting this event.
|14.05||Richard Williams award introduction||Paul Fowler|
|14.15||An in vitro genotoxicity assessment framework for next generation nicotine delivery products||Fiona Chapman|
|14.35||Can Benchmark Dose potency information augment the use of Structural Activity Relationships in Mode of Action-based compound risk assessments?||Ryan Wheeldon|
|14.55||Machine Learning and Mechanistic information from a Multi Endpoint Genotoxicity Screen||Amy Wilson|
|15.25||Application of Adverse Outcome Pathways (AOP) to Support a Genotoxicity Assessment||Steven Kane|
|15.45||Utility of Genotoxicity Adverse Outcome Pathways||Dan Roberts|
|16:30||Genetic Toxicology 2021: Direct Quantification of in vitro and in vivo mutagenesis using Duplex Sequencing||Jesse Salk|
|16:50||In vitro Pig-a assay: obtaining greater data depth using Duplex Sequencing||Anne Ashford|
|17.10||Duplex sequencing questions|
|17:25||Richard Williams award result||Paul Fowler|